CASP3 and melanoma: Regarding the molecular mechanism underlying CONPs, the authors demonstrated that they induced the reduction in melanoma progression by a mitochondrion-mediated apoptosis signaling pathway, causing Cyt-c release and activating caspase-3 and caspase-9.